# Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine

> **NCT01640457** · PHASE1,PHASE2 · COMPLETED · sponsor: **Tetec AG** · enrollment: 120 (actual)

## Conditions studied

- Intervertebral Disc Displacement
- Intervertebral Disc Degeneration

## Interventions

- **DRUG:** NOVOCART® Disc plus
- **DEVICE:** NOVOCART® Disc basic

## Key facts

- **NCT ID:** NCT01640457
- **Lead sponsor:** Tetec AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2018-11-01
- **Final completion:** 2021-06-14
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2021-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640457, "Safety and Efficacy With NOVOCART® Disc Plus (ADCT) for the Treatment of Degenerative Disc Disease in Lumbar Spine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01640457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*